LivaNova (LIVN) Research & Development (2014 - 2026)
LivaNova's (LIVN) quarterly Research & Development came in at $58.7 million in Q1 2026, up 54.95% year-on-year from $37.9 million in Q1 2025, and up 12.61% quarter-over-quarter from $52.1 million in Q4 2025.
LivaNova (LIVN) Research & Development (2014 - 2026) Analysis & Trends
LivaNova has disclosed Research & Development across 13 years of filings, most recently posting $58.7 million for Q1 2026.
- Research & Development for Q1 2026 came in at $58.7 million, up 54.95% year-over-year; the trailing twelve-month figure through Mar 2026 was $206.6 million (up 18.23% YoY), and the FY2025 annual result was $185.8 million, up 1.78% from the prior year.
- Research & Development came in at $58.7 million for Q1 2026 at LivaNova, up from $52.1 million in the prior quarter.
- In the past five years, Research & Development ranged from a high of $58.7 million in Q1 2026 to a low of $34.2 million in Q2 2022.
- The 5-year median for Research & Development is $46.2 million (2023), against an average of $45.7 million.
- Across the five-year window, Research & Development slumped 34.87% in 2022 and surged 54.95% in 2026, its largest moves.
- LivaNova's Research & Development stood at $44.9 million in 2022, then increased by 2.74% to $46.2 million in 2023, then declined by 6.19% to $43.3 million in 2024, then increased by 20.35% to $52.1 million in 2025, then climbed by 12.61% to $58.7 million in 2026.
- The last three Research & Development figures came in at $58.7 million (Q1 2026), $52.1 million (Q4 2025), and $48.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 157.80 Bn | 151.14 Bn | 6.27 Bn | 767.00 Mn |
| 2 | Stryker | 115.54 Bn | 112.66 Bn | 3.81 Bn | 413.00 Mn |
| 3 | Medtronic | 103.44 Bn | 95.27 Bn | 5.76 Bn | 722.00 Mn |
| 4 | Boston Scientific | 72.38 Bn | 71.17 Bn | 3.61 Bn | 516.00 Mn |
| 5 | Edwards Lifesciences | 49.76 Bn | 46.09 Bn | 1.29 Bn | 263.30 Mn |
| 6 | Dexcom | 29.53 Bn | 28.42 Bn | 750.30 Mn | 145.30 Mn |
| 7 | GE HealthCare Technologies | 29.51 Bn | 27.44 Bn | 1.98 Bn | 345.00 Mn |
| 8 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -461.27 Mn |
| 9 | Steris | 20.69 Bn | 20.27 Bn | 697.10 Mn | 28.80 Mn |
| 10 | LivaNova | 4.09 Bn | 3.51 Bn | 243.75 Mn | 58.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 58.70 Mn |
| Dec 31, 2025 | 52.12 Mn |
| Sep 30, 2025 | 48.58 Mn |
| Jun 30, 2025 | 47.19 Mn |
| Mar 31, 2025 | 37.88 Mn |
| Dec 31, 2024 | 43.31 Mn |
| Sep 30, 2024 | 48.81 Mn |
| Jun 30, 2024 | 44.74 Mn |
| Mar 31, 2024 | 45.66 Mn |
| Dec 31, 2023 | 46.17 Mn |
| Sep 30, 2023 | 46.54 Mn |
| Jun 30, 2023 | 51.12 Mn |
| Mar 31, 2023 | 49.99 Mn |
| Dec 31, 2022 | 44.93 Mn |
| Sep 30, 2022 | 35.73 Mn |
| Jun 30, 2022 | 34.23 Mn |
| Mar 31, 2022 | 40.92 Mn |
| Dec 31, 2021 | 44.10 Mn |
| Sep 30, 2021 | 42.13 Mn |
| Jun 30, 2021 | 52.56 Mn |